Johnson & Johnson prepares to resume COVID vaccine trial in US
Johnson & Johnson said Friday it was preparing to resume the clinical trial of its experimental vaccine to fight COVID-19, which was suspended last week after a volunteer fell ill.
J&J said it was "planning to resume recruitment" for the phase 3 trial, which began in late September and should ultimately include 60,000 participants.
"After a thorough evaluation of a serious medical event experienced by one study participant, no clear cause has been identified," the group said in a statement.
"The company has found no evidence that the vaccine candidate caused the event."
© 2020 AFP
Citation:
Johnson & Johnson prepares to resume COVID vaccine trial in US (2020, October 23)
retrieved 25 April 2024
from https://medicalxpress.com/news/2020-10-johnson-resume-covid-vaccine-trial.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
